Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;54 Suppl 6(0 6):17-9.
doi: 10.1111/epi.12267.

Antagomirs and microRNA in status epilepticus

David C Henshall  1
Affiliations
Review

Antagomirs and microRNA in status epilepticus

David C Henshall. Epilepsia. 2013 Sep.

Abstract

MicroRNAs are an important class of noncoding RNA, which function as posttranscriptional regulators of protein levels within cells. Emerging work has revealed that status epilepticus produces select changes to microRNA levels within the brain, which may impact levels of proteins involved in neuronal structure and excitability, gliosis, inflammation, and apoptosis. Animal studies show that targeting microRNAs using locked nucleic acid-modified oligonucleotides ("antagomirs") can have potent effects on status epilepticus, seizure-induced neuronal death, and the later emergence of recurrent spontaneous seizures. Accordingly, microRNA-based therapeutics may have potential as a future treatment of status epilepticus.

Keywords: Epilepsy; Epileptogenesis; Hippocampal sclerosis; Noncoding RNA.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Post-treatment with antagomirs reduces later spontaneous seizures. Mice were injected with antagomirs targeting miR-134 (Ant-134) or a non-targeting scrambled control (Scram) 1 h after triggering status epilepticus and then epilepsy monitoring commenced. Graph shows box-and-whisker plots of data on telemetry (weeks 1-2) and video-monitored (weeks 3-4) spontaneous seizures in mice (n = 5-6 per group; *p < 0.05). Data are adapted from Jimenez-Mateos et al. (2012)
See this image and copyright information in PMC

References

    1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–233. - PMC - PubMed
    1. Elmen J, Lindow M, Silahtaroglu A, Bak M, Christensen M, Lind-Thomsen A, Hedtjarn M, Hansen JB, Hansen HF, Straarup EM, McCullagh K, Kearney P, Kauppinen S. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res. 2008;36:1153–1162. - PMC - PubMed
    1. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010;466:835–840. - PMC - PubMed
    1. Hu K, Xie YY, Zhang C, Ouyang DS, Long HY, Sun DN, Long LL, Feng L, Li Y, Xiao B. MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus. BMC Neurosci. 2012;13:115. - PMC - PubMed
    1. Jimenez-Mateos EM, Bray I, Sanz-Rodriguez A, Engel T, McKiernan R, Mouri G, Tanaka K, Sano T, Saugstad JA, Simon RP, Stallings RL, Henshall DC. MicroRNA expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132. Am J Pathol. 2011;179:2519–2532. - PMC - PubMed

Publication types

LinkOut - more resources